{
  "meta": {
    "title": "00016_Mid_Day_Module_Medicine-5",
    "url": "https://brainandscalpel.vercel.app/00016-mid-day-module-medicine-5-4768f9ef.html",
    "scrapedAt": "2025-11-29T18:11:51.785Z"
  },
  "questions": [
    {
      "id": 6832,
      "choices": [
        {
          "id": 27297,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Sick sinus syndrome </span></span></p>"
        },
        {
          "id": 27298,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Pacemaker syndrome </span></span></p>"
        },
        {
          "id": 27299,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Lead displacement </span></span></p>"
        },
        {
          "id": 27300,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Ventricular tachycardia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 75-year-old patient with long-standing atrial fibrillation (AF) received a VVIR pacemaker. After a few months, he presents with dizziness, fatigue, and visible pulsations in the neck. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q1716418",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022923,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Pacemaker syndrome</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pacemaker syndrome</span></strong><span style=\"font-size:12.0pt\"> is a collection of symptoms caused by a loss of atrioventricular (AV) synchrony due to ventricular pacing. This can occur in patients with single-chamber pacemakers (like VVIR) who have underlying sinus node dysfunction (as suggested by the history of AF).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The symptoms of pacemaker syndrome include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Dizziness and fatigue:</span></strong><span style=\"font-size:12.0pt\"> Due to decreased cardiac output caused by loss of AV synchrony.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Visible neck pulsations:</span></strong><span style=\"font-size:12.0pt\"> Prominent irregular cannon A waves in the JVP due to atrial contraction against a closed tricuspid valve.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Sick sinus syndrome:</span></strong><span style=\"font-size:12.0pt\"> Would not be associated with elevated JVP or cannon &lsquo;a&rsquo; waves. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Lead displacement:</span></strong><span style=\"font-size:12.0pt\"> Lead displacement would likely cause pacing failure or erratic pacing, not the specific symptoms described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ventricular tachycardia:</span></strong><span style=\"font-size:12.0pt\"> This would present with a rapid, regular heart rhythm and different symptoms (palpitations, chest pain, syncope).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;Pacemaker syndrome is a potential complication of single-chamber ventricular pacing (usually VVIR), and presents with dizziness and syncope due to AV dissociation.</span></span></span></p>",
      "correct_choice_id": 27298,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6833,
      "choices": [
        {
          "id": 27301,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Re-entry </span></span></p>"
        },
        {
          "id": 27302,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Delayed afterdepolarizations (DADs) </span></span></p>"
        },
        {
          "id": 27303,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Early afterdepolarizations (EADs) </span></span></p>"
        },
        {
          "id": 27304,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Enhanced automaticity</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most common mechanism of digitalis-induced ventricular arrhythmias?</span></span></p>",
      "unique_key": "Q9225576",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022924,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Delayed afterdepolarizations (DADs)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Digitalis toxicity leads to an increase in intracellular calcium levels within cardiac myocytes. This calcium overload triggers abnormal electrical impulses known as delayed afterdepolarizations (DADs) that occur during phase 4 of action potential. These DADs can reach a threshold and initiate ectopic beats, leading to various ventricular arrhythmias. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Re-entry:&nbsp;</span></strong><span style=\"font-size:12.0pt\">While re-entry is the <em>most common mechanism for arrhythmias</em> in general, it&#39;s not the primary mechanism for digitalis-induced ventricular arrhythmias.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Early afterdepolarizations (EADs):</span></strong><span style=\"font-size:12.0pt\"> EADs are associated with prolonged repolarization (long QT syndrome), which is not a direct effect of digitalis toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Enhanced automaticity:</span></strong><span style=\"font-size:12.0pt\"> Although digitalis can increase automaticity, it&#39;s not the predominant mechanism; DADs caused by calcium overload play a more significant role.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Understand that the primary mechanism of digitalis-induced ventricular arrhythmias is delayed afterdepolarizations (DADs) caused by intracellular calcium overload.</span></span></span></p>",
      "correct_choice_id": 27302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6834,
      "choices": [
        {
          "id": 27305,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Decremental response </span></span></p>"
        },
        {
          "id": 27306,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Sodium-dependent conduction </span></span></p>"
        },
        {
          "id": 27307,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Increased gap junctions </span></span></p>"
        },
        {
          "id": 27308,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Speed of conduction is 1-2 m/s</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following describes the AV node accurately?</span></span></p>",
      "unique_key": "Q4117785",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022925,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Decremental response</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrionodal transitional connections exhibit decremental conduction, defined as slowing of conduction with increasingly rapid rates of stimulation. This property of the atrioventricular (AV) node is physiologically important. If a very rapid atrial arrhythmia occurs, the AV node acts as a sort of &ldquo;gatekeeper&rdquo; to the ventricles due to its decremental conduction. Thus, in the case of atrial fibrillation (where atrial rates often exceed 300 beats/min) the ventricular rate never approaches these very rapid rates. Some accessory conduction pathways, in contrast, do not exhibit decremental conduction properties and will very rapidly conduct tachycardias (such as atrial fibrillation) to the ventricles, leading to hemodynamic collapse.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Sodium-dependent conduction:</span></strong><span style=\"font-size:12.0pt\"> The action potential upstroke in the AV node is dependent on the smaller and slower inward Ca2+ current, which is the reason why the upstroke velocity of the action potential is low&mdash;one of the factors responsible for the slow conduction velocity in the AV node.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Increased gap junctions:</span></strong><span style=\"font-size:12.0pt\"> The AV node actually has fewer gap junctions than other parts of the conduction system, contributing to its slower conduction speed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Speed of conduction is 1-2 m/s:</span></strong><span style=\"font-size:12.0pt\"> The conduction speed in the AV node is much slower, around 0.05 m/s (50 mm/s).</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">AV node acts as a &lsquo;gatekeeper&rsquo; to the ventricles.</span></span></span></p>",
      "correct_choice_id": 27305,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6852,
      "choices": [
        {
          "id": 27376,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">First-degree heart block </span></span></p>"
        },
        {
          "id": 27377,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Mobitz type I, second-degree heart block </span></span></p>"
        },
        {
          "id": 27378,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Mobitz type II, second-degree heart block </span></span></p>"
        },
        {
          "id": 27379,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Complete Heart Block</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are seeing Mr. Aravind, a 24-year-old previously healthy athlete, for his routine physical examination. Which of the following rhythms is demonstrated?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-094521.png\" style=\"height:76px; width:400px\" /></span></span></p>",
      "unique_key": "Q3882837",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022926,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) Mobitz type I, second-degree heart block</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The periodic failure of conduction in Mobitz type I block is characterized by a progressively lengthening PR interval, shortening of the RR interval, and a pause that is less than two times the immediately preceding RR interval on the electrocardiogram (ECG). The ECG complex after the pause exhibits a shorter PR interval than that immediately preceding the pause. This ECG pattern most often arises because of decremental conduction of electrical impulses in the atrioventricular node. This rhythm is usually benign and may be seen in very fit athletes due to high vagal tone. This pattern is typically caused by decremental conduction in the atrioventricular (AV) node. It is generally a benign rhythm and can be seen in healthy athletes due to high vagal tone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. First-degree heart block:</span></strong><span style=\"font-size:12.0pt\"> This has a prolonged but constant PR interval.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mobitz type II, second-degree heart block:</span></strong><span style=\"font-size:12.0pt\"> This has a constant PR interval with occasional dropped QRS complexes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Type III heart block (complete heart block):</span></strong><span style=\"font-size:12.0pt\"> This has complete dissociation between the atria and ventricles, with no relationship between P waves and QRS complexes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mobitz type I second-degree heart block (Wenckebach) is a relatively benign rhythm often seen in athletes due to high vagal tone.</span></span></span></p>",
      "correct_choice_id": 27377,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6854,
      "choices": [
        {
          "id": 27384,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Multiple pathways </span></span></p>"
        },
        {
          "id": 27385,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Refractory period &gt; 240 ms </span></span></p>"
        },
        {
          "id": 27386,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Inducible AF or AVRT </span></span></p>"
        },
        {
          "id": 27387,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Accessory pathway in the posteroseptal region</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT indicative of high risk in Wolff-Parkinson-White (WPW) syndrome?</span></span></p>",
      "unique_key": "Q2408918",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022927,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Refractory period &gt; 240ms</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A <strong>short</strong> refractory period of the accessory pathway (is a high-risk feature in WPW syndrome, as it allows for rapid conduction of impulses from the atria to the ventricles, potentially leading to life-threatening arrhythmia. A refractory period <strong>&gt; 240 ms</strong> indicates a slower conduction pathway and is generally considered <strong>low risk</strong>. Also, exercise TMT demonstrating disappearance of the delta wave and wide QRS at HR &ge; 120 beats/min is also considered low risk since it indicates inability of the accessory pathway to conduct at higher rates.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Multiple pathways:</span></strong><span style=\"font-size:12.0pt\"> The presence of multiple accessory pathways increases the risk of arrhythmias and is a high-risk feature.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Inducible AF or AVRT:</span></strong><span style=\"font-size:12.0pt\"> The ability to induce AF or AV reentrant tachycardia (AVRT) during electrophysiology study indicates a higher risk of spontaneous arrhythmias and is a high-risk feature.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Accessory pathway in the posteroseptal region:</span></strong><span style=\"font-size:12.0pt\"> Poster septal accessory pathways are associated with a higher risk of sudden cardiac death due to their potential to conduct rapidly during AF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">High risk in WPW = multiple accessory pathways, accessory pathway refractory period &lt; 240ms, inducible AVRT or AF in EPS &amp; shortest RR in AF &le; 250ms.</span></span></span></p>",
      "correct_choice_id": 27385,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6858,
      "choices": [
        {
          "id": 27400,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">It is usually life-threatening. </span></span></p>"
        },
        {
          "id": 27401,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">It relies on enhanced automaticity as a mechanism. </span></span></p>"
        },
        {
          "id": 27402,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">It relies on multiple pathways for conduction from the atrium into the AV node. </span></span></p>"
        },
        {
          "id": 27403,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">It requires systemic anticoagulation for thromboembolic prophylaxis.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following statements is true regarding the most common form of paroxysmal supraventricular tachycardia (PSVT)?</span></span></span></p>",
      "unique_key": "Q2563783",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022928,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) It relies on multiple pathways for conduction from the atrium into the AV node.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common form of PSVT is atrioventricular nodal reentrant tachycardia (AVNRT). AVNRT is caused by the presence of multiple pathways within or near the AV node, allowing for re-entry circuits to form and sustain the tachycardia. Most forms of AVNRT utilize a slowly conducting AV nodal pathway that is located as a right inferior extension that extends from the compact AV node near the His bundle, inferiorly along the tricuspid valve annulus to the floor of the coronary sinus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. It is usually life-threatening:</span></strong><span style=\"font-size:12.0pt\">&nbsp; AVNRT is usually not life-threatening, though it can cause significant symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. It relies on enhanced automaticity as a mechanism: </span></strong><span style=\"font-size:12.0pt\">&nbsp;AVNRT is a re-entry tachycardia, not caused by enhanced automaticity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. It requires systemic anticoagulation for thromboembolic prophylaxis: </span></strong><span style=\"font-size:12.0pt\">Anticoagulation is not typically required for AVNRT unless there are additional risk factors for thromboembolism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common form of PSVT is AVNRT, which is caused by re-entry circuits involving multiple pathways within the AV node.</span></span></span></p>",
      "correct_choice_id": 27402,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20103,
      "choices": [
        {
          "id": 80373,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal residual volume (RV) </span></span></span></p>"
        },
        {
          "id": 80374,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased forced vital capacity (FVC) </span></span></span></p>"
        },
        {
          "id": 80375,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal vital capacity (VC) </span></span></span></p>"
        },
        {
          "id": 80376,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased FEV1/FVC ratio</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man with a history of smoking and progressive dyspnea presents with a barrel chest and expiratory wheezing. Which PFT finding is LEAST likely in this patient with suspected emphysema?</span></span></span></p>",
      "unique_key": "Q5675700",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022929,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A) Normal residual volume (RV)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></u></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emphysema, a type of COPD, is characterized by air trapping and hyperinflation, leading to increased residual volume.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></strong></span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased forced vital capacity (FVC)</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common in emphysema due to air trapping.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Normal vital capacity (VC):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While possible in early disease, VC often decreases as emphysema progresses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D. Decreased FEV1/FVC ratio:</strong> Hallmark of obstructive lung disease like emphysema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></u></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In emphysema, expect increased residual volume (RV) due to air trapping, along with decreased FEV1/FVC ratio and forced vital capacity (FVC).</span></span></p>",
      "correct_choice_id": 80373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20105,
      "choices": [
        {
          "id": 80381,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal lung function </span></span></span></p>"
        },
        {
          "id": 80382,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Restrictive lung disease </span></span></span></p>"
        },
        {
          "id": 80383,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Upper airway obstruction </span></span></span></p>"
        },
        {
          "id": 80384,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obstructive lung disease</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient&#39;s flow-volume (FV) loop demonstrates the following (red line in the image is the patients actual FV loop, background blue line is the predicted normal). What does this finding indicate?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/picture2.jpg\" style=\"height:298px; width:300px\" /></span></span></p>",
      "unique_key": "Q7284834",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022930,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Obstructive lung disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></u></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The concave shape with scooped appearance of expiratory limb and reduced PEFR on the expiratory limb are classic for obstructive lung diseases like COPD and asthma, indicating airflow limitation during exhalation. The patient also has a near normal FVC, further strengthening the diagnosis of obstruction. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Normal lung function:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Normal flow-volume loops are relatively linear.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Restrictive lung disease:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Usually shows a smaller loop with normal shape.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Upper airway obstruction:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Typically shows flattening on the inspiratory limb of the flow-volume loop.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></u></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A concave, scooped expiratory flow-volume loop with reduced PEFR is indicative of obstructive lung disease such as COPD or asthma.</span></span></p>",
      "correct_choice_id": 80384,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6859,
      "choices": [
        {
          "id": 27404,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">AF with pre-excitation </span></span></p>"
        },
        {
          "id": 27405,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">AF with LBBB </span></span></p>"
        },
        {
          "id": 27406,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Monomorphic VT </span></span></p>"
        },
        {
          "id": 27407,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Torsades de pointes</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">You are in the emergency department when a 19-year-old woman, Ms. Vidhya, arrives after collapsing during a Sunday marathon. She is unresponsive and pulseless. ECG is shown. Which of the following rhythms is the cause of her cardiac arrest?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-095925.png\" style=\"height:241px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q1956397",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022931,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Atrial fibrillation with pre-excitation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rapid, irregular, broad complex tachycardia (overall rate ~ 200 bpm) with a LBBB morphology (dominant S wave in V1). This could easily be mistaken for AF with LBBB.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, the morphology is not typical of LBBB, the rate is too rapid (up to 300 bpm in places, i.e. too rapid to be conducted via the AV node), and there is a subtle beat-to-beat variation in the QRS width which is more typical of WPW (LBBB usually has fixed width QRS complexes).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The rhythm is very difficult to differentiate from polymorphic VT but it does not have the twisting morphology to consider it as Torsades de pointes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note: </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Approximately 25% of APs causing preexcitation allow minimum R-to-R intervals of &lt;250 ms during AF and are associated with a higher risk of inducing ventricular fibrillation and sudden death.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pre-excited AF should be treated with electrical cardioversion or IV procainamide or ibutilide, which may terminate the arrhythmia or slow the ventricular rate. <em><u>AV nodal blockers are absolutely C/I.</u></em> </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Atrioventricular nodal reentrant tachycardia: </span></strong><span style=\"font-size:12.0pt\">This is usually a narrow-complex tachycardia, unlike the wide-complex seen in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Monomorphic ventricular tachycardia:</span></strong><span style=\"font-size:12.0pt\"> This has a regular rhythm with similar QRS complexes, unlike the irregular pattern seen here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Torsades de pointes:</span></strong><span style=\"font-size:12.0pt\"> Difficult to differentiate but the given ECG does not have the twisting morphology to consider it as Torsades de pointes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">AF with preexcitation presents with rapid irregular wide-complex tachycardia and it is lethal. </span></span></span></p>",
      "correct_choice_id": 27404,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54253,
      "choices": [
        {
          "id": 216481,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">No anticoagulation</span></span></p>"
        },
        {
          "id": 216482,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Initiate aspirin 325 mg daily </span></span></p>"
        },
        {
          "id": 216483,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Initiate apixaban 5 mg twice daily </span></span></p>"
        },
        {
          "id": 216484,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Initiate warfarin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ms. Kavitha, a 22-year-old woman with rheumatic mitral stenosis develops atrial fibrillation. Her CHA₂DS₂-VASc is 1. Which of the following is the correct approach to stroke prevention?</span></span></p>",
      "unique_key": "Q2161683",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022932,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) Initiate warfarin</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While Ms. Kavitha&#39;s CHA₂DS₂-VASc score is 1, her rheumatic mitral stenosis places her at high risk for stroke due to AF. Warfarin is the recommended anticoagulant for patients with rheumatic mitral stenosis and AF, as the newer direct-acting oral anticoagulants (DOACs) have not been adequately studied in this population.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. No anticoagulation: </span></strong><span style=\"font-size:12.0pt\">&nbsp;Incorrect, since AF increases the risk of stroke by 20-25x in patients with mitral stenosis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Initiate aspirin 325 mg daily: </span></strong><span style=\"font-size:12.0pt\">&nbsp;Insufficient for stroke prevention in patients with AF and high risk factors like rheumatic mitral stenosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Initiate apixaban 5 mg twice daily:</span></strong><span style=\"font-size:12.0pt\"> &nbsp;DOACs are not recommended in patients with rheumatic mitral stenosis due to limited data.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> &nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin is the recommended anticoagulant for stroke prevention in patients with AF and rheumatic mitral stenosis.</span></span></span></p>",
      "correct_choice_id": 216484,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53711,
      "choices": [
        {
          "id": 214317,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Balloon aortic valvuloplasty</span></span></span></p>"
        },
        {
          "id": 214318,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continued medical therapy </span></span></span></p>"
        },
        {
          "id": 214319,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Surgical aortic valve replacement </span></span></span></p>"
        },
        {
          "id": 214320,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transcatheter aortic valve implantation (TAVI)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 78-year-old woman presents with exertional dyspnea, and chest pain. Echo was done and showed severe aortic stenosis, He has hypertension, chronic kidney disease (stage G4), hyperlipidemia, severe COPD, and atrial fibrillation. What is the most appropriate next step in treatment?</span></span></span></p>",
      "unique_key": "Q7458128",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022933,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) Transcatheter aortic valve implantation (TAVI)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TAVI is recommended for symptomatic patients with severe aortic stenosis who are at high or prohibitive risk for SAVR. TAVI is less invasive than SAVR and has shown similar outcomes in high-risk patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Balloon aortic valvuloplasty:</span></strong><span style=\"font-size:12.0pt\"> Temporary solution, not recommended for definitive treatment of severe AS. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Continued medical therapy</span></strong><span style=\"font-size:12.0pt\">: Not appropriate for symptomatic severe AS, as it does not address the underlying valvular issue. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Surgical aortic valve replacement:</span></strong><span style=\"font-size:12.0pt\"> High risk in this patient due to comorbidities and age.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transcatheter aortic valve implantation is recommended in preference to surgical aortic valve replacement for symptomatic patients with severe aortic stenosis who are older than 80 years or younger patients with a life expectancy less than 10 years.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transcatheter aortic valve implantation is recommended for symptomatic patients of any age with severe aortic stenosis and a high or prohibitive surgical risk if predicted post procedure survival is more than 12 months with an acceptable quality of life.</span></span></span></p>",
      "correct_choice_id": 214320,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53713,
      "choices": [
        {
          "id": 214325,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bicuspid aortic valve</span></span></p>"
        },
        {
          "id": 214326,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertrophic cardiomyopathy (HCM) </span></span></p>"
        },
        {
          "id": 214327,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Restrictive membranous ventricular septal defect (VSD) </span></span></p>"
        },
        {
          "id": 214328,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ruptured sinus of Valsalva aneurysm</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old man presents with fatigue and near-syncope with exertion. He has a 3/6 systolic ejection murmur along the right upper sternal border that increases with squatting. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q6404743",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022934,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>A) Bicuspid aortic valve</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A systolic ejection murmur along the right upper sternal border that increases with squatting is a classic finding of a <strong>bicuspid aortic valve (BAV)</strong>. BAV is a congenital abnormality where the aortic valve has two leaflets instead of three. This can lead to aortic stenosis over time, causing symptoms like fatigue, dyspnea, and syncope with exertion. Squatting increases venous return and left ventricular volume, which accentuates the murmur in aortic stenosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hypertrophic cardiomyopathy (HCM):</span></strong><span style=\"font-size:12.0pt\"> The murmur of HCM is typically heard best at the left lower sternal border and decreases with squatting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Restrictive membranous ventricular septal defect (VSD):</span></strong><span style=\"font-size:12.0pt\"> VSDs typically present with a holosystolic murmur, not a systolic ejection murmur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ruptured sinus of Valsalva aneurysm:</span></strong><span style=\"font-size:12.0pt\"> This typically presents with a continuous murmur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Systolic ejection murmur along the right upper sternal border that increases with squatting as a classic finding of a bicuspid aortic valve.</span></span></span></p>",
      "correct_choice_id": 214325,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53716,
      "choices": [
        {
          "id": 214337,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intra-aortic balloon pump placement</span></span></p>"
        },
        {
          "id": 214338,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous dobutamine</span></span></p>"
        },
        {
          "id": 214339,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous 0.9% saline</span></span></p>"
        },
        {
          "id": 214340,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral metoprolol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 73-year-old man presents with a 3 hour history of chest pain. His BP is 80/50 mmHg, HR is 120/min and has elevated JVP and clear lungs. ECG is shown. What is the most appropriate treatment<strong>?</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-135849.jpg\" style=\"height:397px; width:500px\" /></strong></span></span></span></p>",
      "unique_key": "Q3197030",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022935,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Intravenous 0.9% saline</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient is likely experiencing right ventricular (RV) infarction, a complication of inferior MI. The key features suggestive of RV infarction are hypotension, elevated central venous pressure, clear lungs, and ST-segment elevation in lead V4R. Intravenous fluids are the first-line treatment to increase RV preload and improve cardiac output.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Intra-aortic balloon pump placement:</span></strong><span style=\"font-size:12.0pt\"> Indicated in cardiogenic shock with LV dysfunction, but not the first-line treatment for RV infarction. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Intravenous dobutamine:</span></strong><span style=\"font-size:12.0pt\"> Inotrope may be considered if fluids are ineffective, but not the initial management. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Oral metoprolol:</span></strong><span style=\"font-size:12.0pt\"> Beta-blockers can worsen hypotension and should be avoided in RV infarction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with an inferior myocardial infarction with right ventricular involvement and hypotension should receive intravenous fluids.</span></span></span></p>",
      "correct_choice_id": 214339,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53717,
      "choices": [
        {
          "id": 214341,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac magnetic resonance imaging (MRI)</span></span></p>"
        },
        {
          "id": 214342,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surgical mitral valve repair</span></span></p>"
        },
        {
          "id": 214343,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transcatheter mitral valve repair (TMVR)</span></span></p>"
        },
        {
          "id": 214344,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transesophageal echocardiography (TEE)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with atrial fibrillation and severe primary mitral regurgitation (MR) due to mitral valve prolapse has an LVEF of 55% and LV end-systolic dimension of 60 mm. What is the most appropriate next step in management?</span></span></p>",
      "unique_key": "Q7824979",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022936,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Surgical mitral valve repair</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Surgical mitral valve repair is the first-line therapy for patients with primary severe MR who meet the criteria for intervention (symptomatic or asymptomatic with LV enlargement/dysfunction).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cardiac magnetic resonance imaging (MRI):</span></strong><span style=\"font-size:12.0pt\"> Unnecessary if the mechanism and severity of MR are already established by TTE. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Transcatheter mitral valve repair (TMVR):</span></strong><span style=\"font-size:12.0pt\"> Considered in patients with favourable anatomy and high risk for surgical repair. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Transesophageal echocardiography (TEE):</span></strong><span style=\"font-size:12.0pt\"> May be helpful if TTE is inconclusive, but not necessary in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Surgery for chronic primary severe mitral regurgitation is indicated in the presence of symptoms, left ventricular dilation, or reduced ejection fraction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Surgical mitral valve repair is first-line therapy for patients with primary severe mitral regurgitation meeting indications for intervention.</span></span></span></p>",
      "correct_choice_id": 214342,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53718,
      "choices": [
        {
          "id": 214345,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop warfarin and start bivalirudin</span></span></p>"
        },
        {
          "id": 214346,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop warfarin and start dabigatran</span></span></p>"
        },
        {
          "id": 214347,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop warfarin and start subcutaneous dose-adjusted unfractionated heparin (UFH)</span></span></p>"
        },
        {
          "id": 214348,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue warfarin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman with a mechanical mitral valve prosthesis is planning pregnancy. She is currently on warfarin 4mg with a stable INR of 3.0. What is the most appropriate anticoagulation strategy during the first trimester?</span></span></p>",
      "unique_key": "Q3107100",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022937,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>D) Continue warfarin</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin is the preferred anticoagulant during pregnancy for women with mechanical heart valves if the dose is 5 mg/d or less. It is the most studied anticoagulant in this population and has established safety and efficacy data.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Stop warfarin and start Bivalirudin:</span></strong><span style=\"font-size:12.0pt\"> Not recommended for long-term anticoagulation in pregnancy. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Stop warfarin and start Dabigatran</span></strong><span style=\"font-size:12.0pt\">: Direct oral anticoagulants (DOACs) are not recommended in pregnancy due to limited safety data. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Stop warfarin and start subcutaneous dose-adjusted unfractionated heparin</span></strong><span style=\"font-size:12.0pt\"> <strong>UFH:</strong> Can be considered if warfarin dose is &gt;5 mg/d or if the patient prefers to avoid warfarin during the first trimester.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin is the preferred anticoagulant for pregnant women with mechanical heart valves if the dose is &le;5 mg/d.</span></span></span></p>",
      "correct_choice_id": 214348,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53720,
      "choices": [
        {
          "id": 214353,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac catheterization</span></span></p>"
        },
        {
          "id": 214354,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dobutamine stress echocardiography</span></span></p>"
        },
        {
          "id": 214355,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surgical aortic valve replacement (SAVR)</span></span></p>"
        },
        {
          "id": 214356,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transcatheter aortic valve implantation (TAVI)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 76-year-old man with a history of hypertension and hyperlipidemia presents with exertional dyspnea and elevated BNP. 2D Echo shows EF of 45% and low-flow, low-gradient severe aortic stenosis. What is the most appropriate management?</span></span></p>",
      "unique_key": "Q3539502",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022938,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B)</strong> <strong>Dobutamine stress echocardiography</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dobutamine stress echocardiography is recommended to differentiate between true severe AS and pseudosevere AS (low flow due to reduced LV function).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cardiac catheterization:</span></strong> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In this patient who likely has low cardiac output, direct measurement of the aortic valve gradient by cardiac catheterization (Option A) would result in low gradients that underestimate the severity of the AS, similar to gradient and velocity values on resting echocardiography. Dobutamine catheterization may be performed in lieu of dobutamine echocardiography in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. &amp; option D.</span></strong><span style=\"font-size:12.0pt\"> <strong>Surgical aortic valve replacement &nbsp;(SAVR) or Transcatheter aortic valve implantation (TAVI):</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Proceeding to surgical or transcatheter aortic valve implantation is inappropriate at this time; the resting echo does not adequately differentiate between pseudosevere AS due to insufficient stroke volume and low-flow, low-gradient severe AS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnose low-flow, low-gradient severe symptomatic aortic stenosis.</span></span></p>",
      "correct_choice_id": 214354,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53722,
      "choices": [
        {
          "id": 214361,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue current warfarin dosage</span></span></p>"
        },
        {
          "id": 214362,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease warfarin dosage</span></span></p>"
        },
        {
          "id": 214363,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discontinue warfarin and start aspirin</span></span></p>"
        },
        {
          "id": 214364,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discontinue warfarin and start dabigatran</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man had a mechanical mitral valve replacement 1 year ago. He is currently on warfarin and his INR is 3.4. He now presents with easy bruising and scattered ecchymoses. What is the most appropriate treatment?</span></span></p>",
      "unique_key": "Q1739857",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022939,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>A) Continue current warfarin dosage</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient has a mechanical heart valve, requiring long-term anticoagulation with warfarin to prevent thromboembolic events. His INR is within the therapeutic range for mechanical mitral valves (2.5-3.5). Easy bruising and ecchymoses are common side effects of warfarin and do not necessarily warrant dose adjustment in the absence of significant bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Decreasing warfarin dosage:</span></strong><span style=\"font-size:12.0pt\"> Would increase the risk of thromboembolic events. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Discontinue warfarin and start aspirin:</span></strong><span style=\"font-size:12.0pt\"> Not sufficient for anticoagulation in patients with mechanical valves. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Discontinue warfarin and start dabigatran</span></strong><span style=\"font-size:12.0pt\">: DOACs are not recommended for patients with mechanical valves (based on the data from Re-ALIGN trial). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In patients with a prosthetic cardiac valve, the appropriate INR goal varies by type of valve and valve position, with a goal INR of 3.0 (range 2.5-3.5) for a mechanical valve in the mitral position. Dabigatran is associated with excess bleeding and thrombosis, and the safety of other direct oral anticoagulants has not been assessed.</span></span></span></p>",
      "correct_choice_id": 214361,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53728,
      "choices": [
        {
          "id": 214385,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic regurgitation</span></span></p>"
        },
        {
          "id": 214386,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitral regurgitation</span></span></p>"
        },
        {
          "id": 214387,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitral stenosis</span></span></p>"
        },
        {
          "id": 214388,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulmonic regurgitation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 45-year-old woman is evaluated for an 18-month history of progressive fatigue and dyspnea. Blood pressure is 112/72 mm Hg, pulse rate is 76/min, and respiration rate is normal. The apical impulse is slightly sustained but not displaced. Auscultation is performed at the cardiac apex. Which of the following is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q4961857",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022940,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Mitral stenosis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient has the typical findings of mitral stenosis, including a diastolic opening snap followed by a long, low-frequency diastolic murmur best heard at the apex. The murmur peaks during mid-diastole and again before a loud S1. The murmur of mitral stenosis is best appreciated by auscultating with the bell of the stethoscope with the patient in the left lateral decubitus position.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aortic regurgitation:</span></strong><span style=\"font-size:12.0pt\">&nbsp; Aortic regurgitation produces a high-pitched diastolic murmur heard best along the mid left sternal border.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Mitral regurgitation:</span></strong><span style=\"font-size:12.0pt\">&nbsp; Mitral regurgitation produces a high-pitched holosystolic murmur loudest at the cardiac apex. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pulmonic regurgitation:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The murmur of pulmonic regurgitation is early diastolic, best heard over the left second and third interspaces and increases in intensity with inspiration.</span></span></p>",
      "correct_choice_id": 214387,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53731,
      "choices": [
        {
          "id": 214397,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serial clinical and echocardiographic evaluations</span></span></p>"
        },
        {
          "id": 214398,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surgical mitral valve repair</span></span></p>"
        },
        {
          "id": 214399,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surgical mitral valve replacement</span></span></p>"
        },
        {
          "id": 214400,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transcatheter mitral valve repair</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old woman came for a routine health check-up. She has no symptoms, and on examination, she has a grade 4/6 holosystolic murmur at the apex. 2D Echo demonstrates severe Mitral regurgitation with LVEF of 50%. The left ventricle is moderately dilated with an LV end-systolic dimension (LVESD) of 42 mm. Which of the following is the most appropriate next step in management?</span></span></span></p>",
      "unique_key": "Q1775819",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022941,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Surgical mitral valve repair</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient has severe mitral regurgitation (MR) with left ventricular (LV) dilatation. Although she is currently asymptomatic, the presence of severe MR with EF &le; 60% and LV enlargement (ESD &ge; 40mm) indicates a high risk of future heart failure and adverse outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Repair is preferred over replacement as it preserves the native valve and avoids the need for long-term anticoagulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Serial clinical and echocardiographic evaluations:</span></strong><span style=\"font-size:12.0pt\"> While monitoring is important, it is not the most appropriate next step in this case of severe MR with LV dilatation. Delaying surgery can lead to irreversible LV damage and worsening of symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Surgical mitral valve replacement:</span></strong><span style=\"font-size:12.0pt\"> Replacement is considered if repair is not feasible or if the mitral valve is severely damaged. However, repair is the preferred option whenever possible.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Transcatheter mitral valve repair:</span></strong><span style=\"font-size:12.0pt\"> This is a less invasive option but is currently recommended for patients who are high-risk surgical candidates. This patient is asymptomatic and otherwise healthy, making her a good candidate for surgical repair.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Indications for surgical mitral valve repair in asymptomatic patients include severe primary MR and LV dilatation (ESD &ge; 40mm and/or EF &le; 60%). </span></span></p>",
      "correct_choice_id": 214398,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20361,
      "choices": [
        {
          "id": 81405,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Acute tubular necrosis (ATN) </span></span></span></p>"
        },
        {
          "id": 81406,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prerenal azotemia </span></span></span></p>"
        },
        {
          "id": 81407,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial nephritis (AIN) </span></span></span></p>"
        },
        {
          "id": 81408,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Postrenal obstruction</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man with a history of hypertension presents with acute onset oliguria and elevated creatinine. His blood pressure is 90/60 mmHg, and he reports recent episodes of diarrhea and vomiting. Which of the following is the most likely cause of his AKI?</span></span></p>",
      "unique_key": "Q6552079",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022942,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Prerenal azotemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s history of hypotension, dehydration (from diarrhea and vomiting), and oliguria strongly suggests prerenal AKI, where decreased renal perfusion is the primary cause.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Acute tubular necrosis (ATN):</strong> While possible, it&#39;s less likely in this scenario without a history of nephrotoxic drug exposure or prolonged hypotension</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Acute interstitial nephritis (AIN):</strong> This would typically present with fever, rash, or other signs of allergic reaction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Postrenal obstruction:</strong> Less likely given the absence of urinary symptoms suggestive of obstruction</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the different causes of acute kidney injury (AKI) and to be able to identify prerenal azotemia as the most likely cause in a patient with hypotension, dehydration, and oliguria. Prerenal azotemia is a functional AKI caused by decreased blood flow to the kidneys, often due to volume depletion or low blood pressure.</span></span></span></p>",
      "correct_choice_id": 81406,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20363,
      "choices": [
        {
          "id": 81413,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 40-year-old with baseline creatinine of 1.2 mg/dL, current creatinine of 2.6 mg/dL, and urine output of 0.4 mL/kg/hour for 18 hours. </span></span></span></p>"
        },
        {
          "id": 81414,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 25-year-old with a baseline creatinine of 0.9 mg/dL, current creatinine of 1.8 mg/dL, and anuria for 14 hours. </span></span></span></p>"
        },
        {
          "id": 81415,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 50-year-old with a baseline creatinine of 0.9 mg/dL, current creatinine of 1.5 mg/dL, and anuria for 10 hours.</span></span></span></p>"
        },
        {
          "id": 81416,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 15-year-old with a decrease in eGFR to 30 mL/min/1.73 m&sup2;.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following scenarios would classify a patient as having Stage 3 AKI?</span></span></p>",
      "unique_key": "Q9569965",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022943,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) A 15-year-old with a decrease in eGFR to 30 mL/min/1.73 m&sup2;.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-144229.png\" style=\"height:594px; width:1000px\" /></p>",
      "correct_choice_id": 81416,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53734,
      "choices": [
        {
          "id": 214409,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic stenosis</span></span></p>"
        },
        {
          "id": 214410,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac tamponade</span></span></p>"
        },
        {
          "id": 214411,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitral regurgitation</span></span></p>"
        },
        {
          "id": 214412,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tricuspid regurgitation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 66-year-old man presents with recurrent chest pain and dyspnea. He has a history of hypertension and hyperlipidemia. Physical exam reveals elevated JVP, crackles, and a soft early systolic murmur with an S3 gallop. ECG is shown. Chest X-ray shows pulmonary congestion. What is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-180925.jpg\" style=\"height:259px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q5143210",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022944,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Mitral regurgitation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s presentation is consistent with acute mitral regurgitation (MR) secondary to an inferolateral myocardial infarction (MI). The ECG findings is suggestive of inferior MI with possible posterior MI (see lead V2) and its likely that posteromedial papillary muscle is ruptured in this case (which is supplied by the RCA), leading to Acute MR. The clinical findings of elevated JVP, pulmonary congestion, and an S3 gallop support the diagnosis of acute heart failure, which is a consequence of the severe MR. The soft early systolic murmur and diastolic rumble are also characteristic of MR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aortic stenosis:</span></strong><span style=\"font-size:12.0pt\"> While this can cause heart failure, it would present with a harsh systolic murmur radiating to the carotids, not a soft early systolic murmur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Cardiac tamponade:</span></strong><span style=\"font-size:12.0pt\"> This can cause elevated JVP and distant heart sounds, but it would not typically present with a new murmur or ECG changes of MI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tricuspid regurgitation:</span></strong><span style=\"font-size:12.0pt\"> This would cause a holosystolic murmur that increases with inspiration, not the early systolic murmur described in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute MR usually occurs in association with inferior MI and it is due to rupture of posteromedial papillary muscle. </span></span></p>",
      "correct_choice_id": 214411,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53740,
      "choices": [
        {
          "id": 214433,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esmolol continuous IV infusion titrated to a heart rate of 60&ndash;70 beats/min </span></span></p>"
        },
        {
          "id": 214434,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intra-aortic balloon pump</span></span></p>"
        },
        {
          "id": 214435,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV nitroprusside </span></span></p>"
        },
        {
          "id": 214436,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV norepinephrine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 21-year-old woman with a history of connective tissue disease presents with acute shortness of breath and pulmonary edema. Examination reveals severe aortic regurgitation due to a right coronary cusp avulsion. She is in cardiogenic shock. What intervention is most likely to maintain end-organ perfusion until surgery?</span></span></span></p>",
      "unique_key": "Q7395275",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022945,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) IV nitroprusside</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is experiencing acute, severe aortic regurgitation leading to cardiogenic shock. The goal is to reduce regurgitant blood volume and improve forward flow. Nitroprusside, a vasodilator, decreases systemic vascular resistance (afterload), reducing the pressure gradient driving the regurgitant flow back into the left ventricle.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Esmolol (beta-blocker) continuous IV infusion titrated to a heart rate of 60&ndash;70 beats/min: </span></strong><span style=\"font-size:12.0pt\">Slowing the heart rate increases diastolic time, worsening regurgitation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Intra-aortic balloon pump:</span></strong><span style=\"font-size:12.0pt\"> Contraindicated in severe aortic regurgitation, as it inflates during diastole, further increasing regurgitation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> <strong>IV norepinephrine</strong>: IV norepinephrine and E. Vasopressin: These are vasopressors that increase afterload, which would worsen aortic regurgitation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In acute severe aortic regurgitation with cardiogenic shock, IV nitroprusside can be used as a bridge to surgery by reducing afterload and improving forward flow.</span></span></span></p>",
      "correct_choice_id": 214435,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53748,
      "choices": [
        {
          "id": 214465,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitral stenosis </span></span></p>"
        },
        {
          "id": 214466,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic stenosis </span></span></p>"
        },
        {
          "id": 214467,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitral regurgitation </span></span></p>"
        },
        {
          "id": 214468,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic regurgitation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old female presented with fatigue. Cardiac catheterization is done and it is demonstrated below. What is the diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-140418.jpg\" style=\"height:283px; width:400px\" /></span></span></p>",
      "unique_key": "Q3790326",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022946,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">A) Mitral stenosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image shows a characteristic pressure tracing of mitral stenosis. The key features that point towards this diagnosis are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Elevated left atrial pressure (LA)</span></strong><span style=\"font-size:12.0pt\">: The red line (LA pressure) is significantly higher than the left ventricular pressure (LV pressure) during diastole. This indicates a pressure gradient across the mitral valve, suggesting stenosis (narrowing).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diastolic pressure gradient</span></strong><span style=\"font-size:12.0pt\">: The shaded area between the LA and LV pressure curves during diastole represents the pressure gradient across the mitral valve. In mitral stenosis, this gradient is elevated.</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Aortic stenosis</span></strong><span style=\"font-size:12.0pt\">: This would show a pressure gradient between the left ventricle and the aorta during systole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mitral regurgitation</span></strong><span style=\"font-size:12.0pt\">: This would show a high-pressure V wave in the left atrial pressure tracing during systole, due to blood regurgitating back into the left atrium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Aortic regurgitation</span></strong><span style=\"font-size:12.0pt\">: This would show an elevated left ventricular diastolic pressure and a rapid decline in aortic pressure during diastole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">LA-LV gradient during diastole is characteristic of mitral stenosis. </span></span></span></p>",
      "correct_choice_id": 214465,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53752,
      "choices": [
        {
          "id": 214481,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitral stenosis</span></span></p>"
        },
        {
          "id": 214482,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic stenosis</span></span></p>"
        },
        {
          "id": 214483,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitral regurgitation </span></span></p>"
        },
        {
          "id": 214484,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic regurgitation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man presented with chest pain. Cardiac catheterization is done and it is demonstrated below. What is the diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-140521.jpg\" style=\"height:359px; width:300px\" /></span></span></p>",
      "unique_key": "Q5140110",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022947,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Aortic stenosis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The key finding in the image is a significant pressure gradient between the left ventricle (LV) and the aorta during systole. This pressure gradient indicates that the blood flow from the LV to the aorta is obstructed, which is a hallmark of LVOT obstruction like aortic stenosis. Common symptoms of aortic stenosis include chest pain, syncope and dyspnea (especially during exertion). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Mitral stenosis</span></strong><span style=\"font-size:12.0pt\">: This would show a pressure gradient between the left atrium and left ventricle during diastole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mitral regurgitation</span></strong><span style=\"font-size:12.0pt\">: This would show a high-pressure V wave in the left atrial pressure tracing during systole, due to blood regurgitating back into the left atrium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Aortic regurgitation</span></strong><span style=\"font-size:12.0pt\">: This would show an elevated left ventricular diastolic pressure and a rapid decline in aortic pressure during diastole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">:</span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The pressure gradient between the LV and the aorta during systole is hallmark of LVOT obstruction (like aortic stenosis).</span></span></span></p>",
      "correct_choice_id": 214482,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53679,
      "choices": [
        {
          "id": 214189,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aspirin </span></span></span></p>"
        },
        {
          "id": 214190,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PFO device closure </span></span></span></p>"
        },
        {
          "id": 214191,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin </span></span></span></p>"
        },
        {
          "id": 214192,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Observation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 42-year-old man presents with transient right-sided weakness. Evaluation reveals a small ischemic stroke and a patent foramen ovale (PFO) with right-to-left shunt. What is the most appropriate management?</span></span></p>",
      "unique_key": "Q3042398",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022948,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) PFO device closure</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients younger than 60 years with a PFO and an embolic stroke of undetermined source, PFO closure is recommended to reduce the risk of recurrent stroke.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aspirin</span></strong><span style=\"font-size:12.0pt\">: Antiplatelet therapy alone is less effective than PFO closure in preventing recurrent stroke. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Warfarin</span></strong><span style=\"font-size:12.0pt\">: Anticoagulation may be considered in older patients or those with contraindications to PFO closure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Observation</span></strong><span style=\"font-size:12.0pt\">: Not appropriate due to the high risk of recurrent stroke in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PFO closure is recommended for younger patients (&lt; 60y) with cryptogenic stroke and PFO to reduce the risk of recurrent stroke. </span></span></span></p>",
      "correct_choice_id": 214190,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53683,
      "choices": [
        {
          "id": 214205,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial septal defect (ASD) </span></span></span></p>"
        },
        {
          "id": 214206,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bicuspid aortic valve with aortic regurgitation </span></span></span></p>"
        },
        {
          "id": 214207,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mitral stenosis </span></span></span></p>"
        },
        {
          "id": 214208,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ventricular septal defect (VSD)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 30-year-old man presents with progressive dyspnea, a systolic murmur at the left second intercostal space, a diastolic flow rumble over the tricuspid valve, and fixed splitting of the second heart sound (S2). ECG is shown. What is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-133706.jpg\" style=\"height:264px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q6093794",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022949,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Atrial septal defect (ASD)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of the murmur, fixed splitting of S2, ECG findings (right axis deviation, incomplete RBBB), and right heart enlargement on chest x-ray are characteristic of an ASD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Bicuspid aortic valve with AR</span></strong><span style=\"font-size:12.0pt\">: Would have a diastolic murmur at the left sternal border. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mitral stenosis</span></strong><span style=\"font-size:12.0pt\">: Would have a diastolic murmur at the apex. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. VSD</span></strong><span style=\"font-size:12.0pt\">: Typically presents with a holosystolic murmur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recognize the clinical and ECG findings suggestive of an ASD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">as amyloidosis, should be considered. Serum protein electrophoresis/urine protein electrophoresis and free light-chain analysis may help identify immunoglobulin light-chain amyloidosis.</span></span></p>",
      "correct_choice_id": 214205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53684,
      "choices": [
        {
          "id": 214209,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coarctation of the aorta</span></span></span></p>"
        },
        {
          "id": 214210,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ostium secundum atrial septal defect</span></span></span></p>"
        },
        {
          "id": 214211,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patent ductus arteriosus</span></span></span></p>"
        },
        {
          "id": 214212,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ventricular septal defect</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 30-year-old man is evaluated for exertional dyspnea. On physical examination, a parasternal impulse is noted at the left sternal border. A grade 2/6 systolic murmur is heard at the second left intercostal space with fixed splitting of the S2.&nbsp; Which of the following is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-140334.jpg\" style=\"height:279px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q7603099",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022950,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><strong>B) Ostium secundum atrial septal defect</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most likely diagnosis is ostium secundum atrial septal defect (ASD). This ECG demonstrates the typical findings associated with an ostium secundum ASD, including right axis deviation (negative QRS in lead I with positive QRS in leads II, III, and aVF) and incomplete right bundle branch block (QRS duration &lt;120 ms, prominent S wave in lateral leads, and prominent qR in V1). ASDs are generally classified by their location. Ostium secundum ASDs, the most common type of ASD (75% of cases), are located in the mid portion of the atrial septum and are usually isolated anomalies. Symptoms may include fatigue, exertional dyspnea, arrhythmias, and paradoxical embolism. Clinical findings in patients with an ASD include a parasternal impulse, fixed splitting of the S2, and a pulmonary outflow murmur. A diastolic flow rumble across the tricuspid valve can occur with a large left-to-right shunt.</span></span></span></p>",
      "correct_choice_id": 214210,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53687,
      "choices": [
        {
          "id": 214221,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ASD (Atrial Septal Defect) </span></span></span></p>"
        },
        {
          "id": 214222,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">VSD (Ventricular Septal Defect) </span></span></span></p>"
        },
        {
          "id": 214223,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ebstein&#39;s Anomaly </span></span></span></p>"
        },
        {
          "id": 214224,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TOF (Tetralogy of Fallot)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 24-year-old man presents with palpitations and syncope. On examination, he has a systolic click with a pansystolic murmur in the left lower sternal border and an elevated JVP. He also complains of intermittent bluish discoloration of face during exercise since childhood. ECG is shown. What is the diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-140431.jpg\" style=\"height:227px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q5904229",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022951,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Ebstein&#39;s Anomaly</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s clinical presentation aligns with the characteristic features of Ebstein&#39;s anomaly: <strong>Systolic click and pansystolic murmur (suggestive of TR), Elevated JVP (due to TR), intermittent cyanosis with exertion (due to right-to-left shunting through an ASD) and tall P waves and right axis deviation on ECG (indicate right atrial enlargement).</strong> </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A. ASD:</strong> While ASD can be present in Ebstein&#39;s anomaly, it alone does not explain all the clinical features in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B. VSD:</strong> VSD presents with a harsh holosystolic murmur but not the other findings in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. TOF:</span></strong><span style=\"font-size:12.0pt\"> TOF is a cyanotic congenital heart defect with a different murmur pattern (harsh systolic ejection murmur) and ECG findings.</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Very tall (Himalayan) P waves are a hallmark of Ebstein&rsquo;s anomaly.</span></span></span></p>",
      "correct_choice_id": 214223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53688,
      "choices": [
        {
          "id": 214225,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial septal defect with shunt reversal</span></span></span></p>"
        },
        {
          "id": 214226,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">D-transposition of the great arteries </span></span></span></p>"
        },
        {
          "id": 214227,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patent ductus arteriosus with shunt reversal</span></span></span></p>"
        },
        {
          "id": 214228,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ventricular septal defect with shunt reversal</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An 8-year-old boy from a rural area in tamilnadu presents with fatigue during physical activity, clubbing, and cyanosis in his feet. His hands appear normal. What is the most likely congenital abnormality?</span></span></span></p>",
      "unique_key": "Q9093391",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022952,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Patent ductus arteriosus with shunt reversal</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s differential cyanosis (cyanosis in the lower extremities but not the upper) strongly suggests a patent ductus arteriosus (PDA) with Eisenmenger syndrome. In this condition, pulmonary hypertension develops, reversing the shunt through the PDA and causing deoxygenated blood to flow into the descending aorta.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Atrial septal defect with shunt reversal:</span></strong><span style=\"font-size:12.0pt\"> While ASDs can lead to Eisenmenger syndrome, the cyanosis would be central, affecting both upper and lower extremities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. D-transposition of the great arteries:</span></strong><span style=\"font-size:12.0pt\"> This typically presents with severe central cyanosis (nit differential) shortly after birth, not later in childhood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ventricular septal defect with shunt reversal:</span></strong><span style=\"font-size:12.0pt\"> Similar to ASD, VSDs can lead to Eisenmenger syndrome, but cyanosis would be central, not differential.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Differential cyanosis (lower extremity cyanosis with sparing of the upper extremities) is a hallmark of a PDA with Eisenmenger syndrome.</span></span></span></p>",
      "correct_choice_id": 214227,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53691,
      "choices": [
        {
          "id": 214237,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bicuspid aortic valve with aortic diameter &lt;45 mm </span></span></span></p>"
        },
        {
          "id": 214238,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Partial anomalous pulmonary venous return without pulmonary hypertension </span></span></span></p>"
        },
        {
          "id": 214239,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe native aortic coarctation </span></span></span></p>"
        },
        {
          "id": 214240,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Systemic right ventricle</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following congenital cardiovascular abnormalities would provide the highest maternal risk in the setting of pregnancy?</span></span></p>",
      "unique_key": "Q8907438",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022953,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Severe native aortic coarctation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe native aortic coarctation poses the highest maternal risk during pregnancy due to the increased risk of aortic dissection or rupture. The elevated blood pressure and increased cardiac output during pregnancy can put significant stress on the narrowed aorta. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Risk of cardiac disease and pregnancy is summarised below -</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">WHO Class I:</span></strong><span style=\"font-size:12.0pt\"> MVP, PDA, PS, repaired ASD/VSD, isolated APC/VPC. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">WHO Class II:</span></strong><span style=\"font-size:12.0pt\"> Unrepaired ASD/VSD, repaired TOF, most arrhythmias.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">WHO Class II-III:</span></strong><span style=\"font-size:12.0pt\"> Repaired CoA, HCM, Mild LV dysfunction, Marfan without AoD, BAV + Ao &lt; 4.5cm</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>WHO Class III: </strong>CyCHD, Fontan, systemic RV, Marfan + Ao &ge; 4cm, BAV + Ao &ge; 4.5cm, Mechanical valve</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>WHO Class IV (pregnancy C/I)</strong>: PAH, LVEF &lt; 30%, severe CoA, Marfan + Ao &ge; 4.5cm, BAV + Ao &ge; 5cm, severe MS/AS, PPCM with residual LV dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Bicuspid aortic valve with aortic diameter &lt;45 mm</span></strong><span style=\"font-size:12.0pt\">: While a bicuspid aortic valve can be associated with aortic dilation, the risk is lower if the aortic diameter is less than 45 mm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Partial anomalous pulmonary venous return without pulmonary hypertension</span></strong><span style=\"font-size:12.0pt\">: This condition is generally well-tolerated and poses a lower risk in pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Systemic right ventricle</span></strong><span style=\"font-size:12.0pt\">: While this can be associated with complex congenital heart disease, it does not carry the same immediate risk of aortic complications as severe coarctation.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe aortic coarctation is a high-risk condition in pregnancy due to the increased risk of aortic dissection or rupture.</span></span></p>",
      "correct_choice_id": 214239,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53694,
      "choices": [
        {
          "id": 214249,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anakinra </span></span></span></p>"
        },
        {
          "id": 214250,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Colchicine and intravenous immune globulin (IVIG) </span></span></span></p>"
        },
        {
          "id": 214251,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ibuprofen </span></span></span></p>"
        },
        {
          "id": 214252,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ibuprofen, colchicine, and prednisone</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 48-year-old man is evaluated for recurrent pericarditis. He has had two prior episodes, both successfully treated with ibuprofen and colchicine. His current symptoms include fever, pulsus paradoxus, a pericardial friction rub, and widespread ST-segment elevation on ECG. Echocardiogram shows a small pericardial effusion without tamponade. What is the most appropriate treatment?</span></span></span></p>",
      "unique_key": "Q8031880",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022954,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) Ibuprofen, colchicine, and prednisone</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient has recurrent pericarditis, defined as a recurrence after a symptom-free interval of 4-6 weeks following the initial episode. Since he has already been treated with ibuprofen and colchicine, the most appropriate treatment for this recurrence is triple therapy with ibuprofen, colchicine, and a glucocorticoid like prednisone. This combination has been shown to be more effective in reducing recurrence rates compared to colchicine and NSAIDs alone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Anakinra</span></strong><span style=\"font-size:12.0pt\">: This is an interleukin-1 receptor antagonist used for refractory cases of recurrent pericarditis that have not responded to other treatments. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Colchicine and IVIG</span></strong><span style=\"font-size:12.0pt\">: This combination is also used for refractory cases, but glucocorticoids should be added first. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ibuprofen alone</span></strong><span style=\"font-size:12.0pt\">: Unlikely to be effective for recurrent pericarditis, especially since it has been used previously.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In patients with recurrent pericarditis initially treated with both colchicine and an NSAID, the addition of a glucocorticoid should be considered.</span></span></span></p>",
      "correct_choice_id": 214252,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53695,
      "choices": [
        {
          "id": 214253,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral Amoxicillin </span></span></span></p>"
        },
        {
          "id": 214254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral Azithromycin </span></span></span></p>"
        },
        {
          "id": 214255,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IV Clindamycin </span></span></span></p>"
        },
        {
          "id": 214256,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">No endocarditis prophylaxis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man had an atrial septal defect (ASD) closure one year ago. He is now scheduled for tooth extraction and periodontal cleaning. The dentist recommended a nil per oral (NPO) 8 hours prior to the procedure. What is the choice for IE prophylaxis?</span></span></p>",
      "unique_key": "Q4399622",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022955,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) No endocarditis prophylaxis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IE prophylaxis is not recommended for patients with repaired ASDs who do not have residual shunts or other high-risk features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IE prophylaxis is indicated only for patients at high risk for infective endocarditis who are about to undergo gingival manipulation or other procedures that break the oral mucosa.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The highest risk for IE is in patients with a prosthetic valve, previous IE, or cyanotic congenital heart disease or repaired congenital heart disease with residual flow disturbances. Other indications include cardiac transplantation valvulopathy, prosthetic material used for cardiac valve repair, and a cardiac defect that has been repaired with prosthetic material within the previous 6 months.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">A), B), C):</span></strong><span style=\"font-size:12.0pt\"> These are antibiotics used for endocarditis prophylaxis but are not indicated in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endocarditis prophylaxis is not routinely recommended for dental procedures in patients with repaired ASDs unless there are specific high-risk features.</span></span></span></p>",
      "correct_choice_id": 214256,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53697,
      "choices": [
        {
          "id": 214261,
          "text": "<p><span style=\"font-size:12.0pt;\">Large pericardial effusion</span></p>"
        },
        {
          "id": 214262,
          "text": "<p><span style=\"font-size:12.0pt;\">No pericardial effusion</span></p>"
        },
        {
          "id": 214263,
          "text": "<p><span style=\"font-size:12.0pt;\">LV dilatation</span></p>"
        },
        {
          "id": 214264,
          "text": "<p><span style=\"font-size:12.0pt;\">Indeterminate study</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient evaluated for cough is found to have an enlarged cardiac silhouette on chest radiography. He is suspected of having pericardial effusion. Ultrasonography is performed with the probe placed in the subxiphoid area. The results are shown. Which of the following is the most likely interpretation of this study?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202024-12-14%20at%2009.53.39.jpeg\" width=\"1280\" height=\"720\"></span></p>",
      "unique_key": "Q6932795",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022956,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans.</strong><span style=\"font-size:14.6667px;\">&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) Large pericardial effusion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient's ultrasound shows a large, circumferential pericardial effusion (arrows) with evidence of cardiac tamponade. An anechoic space is seen between the liver in the near field and the myocardium of the heart and also surrounds the entire heart, indicating a large effusion. Cardiac tamponade is typically seen as collapse of the right atrium or the right ventricle during the diastolic phase of the cardiac cycle. In this study, although the right ventricular free wall appears to “wiggle,” this is caused by inward diastolic movement typical in tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. No pericardial effusion:</strong> This option is incorrect because the ultrasound clearly demonstrates the presence of a significant anechoic space around the heart, indicating a pericardial effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. LV dilatation:</strong> Left ventricular (LV) dilatation is not indicated by the findings described in this scenario. The primary abnormality is the pericardial effusion, not an intrinsic abnormality of the left ventricle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Indeterminate study</strong>: This option is incorrect because the ultrasound findings are definitive for a large pericardial effusion. There is no indication that the study is inconclusive or indeterminate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A large pericardial effusion is characterized by the accumulation of fluid around the heart, visible as an anechoic space on ultrasound. It can lead to cardiac tamponade, a life-threatening condition that requires prompt recognition and management.</span></p>",
      "correct_choice_id": 214261,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53698,
      "choices": [
        {
          "id": 214265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cardiac tamponade</span></span></span></p>"
        },
        {
          "id": 214266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Constrictive pericarditis </span></span></span></p>"
        },
        {
          "id": 214267,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary embolism </span></span></span></p>"
        },
        {
          "id": 214268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary hypertension</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old woman with SLE presents with progressive dyspnea, fatigue, chest fullness, and bilateral peripheral edema. She is febrile and her JVP is elevated. ECG is shown. What is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-124716.jpg\" style=\"height:283px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q3026721",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022957,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Cardiac tamponade</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s clinical presentation, including fever, jugular venous distention and electrical alternans on ECG are suggestive of cardiac tamponade. Cardiac tamponade is a life-threatening condition where fluid accumulation in the pericardial sac compresses the heart, impairing its ability to pump blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Constrictive pericarditis</span></strong><span style=\"font-size:12.0pt\">: Although it can present with similar symptoms, it usually has a more insidious onset and does not typically cause electrical alternans on ECG. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pulmonary embolism</span></strong><span style=\"font-size:12.0pt\">: Can cause dyspnea and elevated JVP, but it would not typically present with electrical alternans. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pulmonary hypertension</span></strong><span style=\"font-size:12.0pt\">: Less likely in the absence of lung disease or right heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Electrical alternans is a hallmark of cardiac tamponade.</span></span></span></p>",
      "correct_choice_id": 214265,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53700,
      "choices": [
        {
          "id": 214273,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intracranial hemorrhage </span></span></span></p>"
        },
        {
          "id": 214274,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stroke </span></span></span></p>"
        },
        {
          "id": 214275,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heart failure </span></span></span></p>"
        },
        {
          "id": 214276,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aortic dissection</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man is evaluated for a 2-day history of fever, malaise, and heart murmur. Today, crops of nonpainful cutaneous lesions have appeared on his feet as shown. Given the diagnosis, the patient is at risk of all of the following except?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184301.jpg\" style=\"height:257px; width:400px\" /></span></span></p>",
      "unique_key": "Q4607365",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022958,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) Aortic dissection</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image demonstrates Janeway lesions. These are nonpainful, macular (occasionally nodular), blanching lesions located on the palms of the hands and soles of the feet; they&nbsp; are associated with infective endocarditis and considered to be a part of vascular phenomenon. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coming back to the case - fever, malaise and a new heart murmur also strongly suggests infective endocarditis. While IE can rarely cause mycotic aneurysms (common the brain), aortic dissection is not a direct complication of infective endocarditis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Intracranial hemorrhage:</span></strong><span style=\"font-size:12.0pt\"> Septic emboli from IE can lodge in the brain, causing intracranial hemorrhage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Stroke:</span></strong><span style=\"font-size:12.0pt\"> Septic emboli can also cause ischemic stroke.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Heart failure:</span></strong><span style=\"font-size:12.0pt\"> Valve damage from IE can lead to heart failure.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic complications are uncommon in endocarditis. </span></span></p>",
      "correct_choice_id": 214276,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53701,
      "choices": [
        {
          "id": 214277,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic thromboembolic pulmonary hypertension</span></span></span></p>"
        },
        {
          "id": 214278,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Constrictive pericarditis</span></span></span></p>"
        },
        {
          "id": 214279,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary hyperparathyroidism</span></span></span></p>"
        },
        {
          "id": 214280,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Restrictive cardiomyopathy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 60-year-old man is evaluated for chronic right-sided heart failure. Chest radiographs are shown. Which of the following is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184320.jpg\" style=\"height:204px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q3389348",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022959,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Constrictive pericarditis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most likely diagnosis is constrictive pericarditis. This chest radiograph shows pericardial calcification on both the posterior-anterior (black arrow) and lateral views (white arrows). Constrictive pericarditis is characterized by pericardial thickening, fibrosis, and sometimes calcification that impair diastolic filling and limit total cardiac volume. Chest radiography or CT may demonstrate partial or circumferential pericardial calcification, and CT or cardiac magnetic resonance imaging may demonstrate pericardial thickening (&gt;3 mm). Importantly, constriction may exist in the absence of these findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Chronic thromboembolic pulmonary hypertension: </span></strong><span style=\"font-size:12.0pt\">This condition involves pulmonary artery obstruction due to organized clots, leading to increased pulmonary artery pressure and right-sided heart failure. However, it would not typically present with pericardial calcification on chest radiographs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Primary hyperparathyroidism: </span></strong><span style=\"font-size:12.0pt\">While primary hyperparathyroidism can cause hypercalcemia and possibly lead to calcifications in various tissues, it is not typically associated with pericardial calcification or the symptoms of chronic right-sided heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Restrictive cardiomyopathy</span></strong><span style=\"font-size:12.0pt\">: Restrictive cardiomyopathy causes diastolic dysfunction due to myocardial stiffness but does not involve pericardial calcification. The imaging findings and clinical presentation are more consistent with constrictive pericarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Constrictive pericarditis is characterized by pericardial thickening and calcification that leads to impaired cardiac filling and chronic right-sided heart failure. Radiographic evidence of pericardial calcification is a key diagnostic clue.</span></span></span></p>",
      "correct_choice_id": 214278,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53706,
      "choices": [
        {
          "id": 214297,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cardiac tamponade </span></span></span></p>"
        },
        {
          "id": 214298,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Constrictive pericarditis </span></span></span></p>"
        },
        {
          "id": 214299,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tricuspid regurgitation </span></span></span></p>"
        },
        {
          "id": 214300,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tricuspid stenosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 43-year-old patient presents with edema and elevated jugular venous pressure (JVP). The JVP pressure tracing is shown below. What is the diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184409.jpg\" style=\"height:231px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q1113602",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022960,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Constrictive pericarditis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of edema, elevated JVP, and prominent x and y descents on the JVP tracing is highly suggestive of constrictive pericarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Prominent x descent:</span></strong><span style=\"font-size:12.0pt\"> This reflects the rapid atrial emptying during early ventricular systole due to the rigid pericardium limiting ventricular filling.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Prominent y descent:</span></strong><span style=\"font-size:12.0pt\"> This represents the rapid ventricular filling during early diastole as the tricuspid valve opens, also due to the constraint imposed by the pericardium.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cardiac tamponade:</span></strong><span style=\"font-size:12.0pt\"> In cardiac tamponade, the x descent is typically absent or minimal, and the y descent is blunted or slow.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tricuspid regurgitation:</span></strong><span style=\"font-size:12.0pt\"> This would cause a prominent v wave in the JVP tracing, not a prominent x descent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tricuspid stenosis:</span></strong><span style=\"font-size:12.0pt\"> Tricuspid stenosis would cause a slow y descent, but the x descent would be normal or blunted.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prominent x and y descent is characteristic of constrictive pericarditis. The prominent &lsquo;y&rsquo; descent of constrictive pericarditis is also called as &lsquo;friedrich sign&rsquo;. </span></span></span></p>",
      "correct_choice_id": 214298,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53708,
      "choices": [
        {
          "id": 214305,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute pericarditis </span></span></span></p>"
        },
        {
          "id": 214306,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dressler&#39;s syndrome </span></span></span></p>"
        },
        {
          "id": 214307,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary embolism </span></span></span></p>"
        },
        {
          "id": 214308,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recurrent MI</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man presents with pleuritic chest pain, fever, and malaise two weeks after a myocardial infarction (MI). On auscultation, you hear a multiphasic rub. His CRP levels are elevated, and troponin levels are slightly elevated but unchanged compared to previous values. ECG shows new ST elevations. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q8929223",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022961,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Dressler&#39;s syndrome</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s presentation is classic for Dressler&#39;s syndrome:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Timing:</span></strong><span style=\"font-size:12.0pt\"> Occurs 1-8 weeks after MI.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Symptoms:</span></strong><span style=\"font-size:12.0pt\"> Pleuritic chest pain, fever, malaise.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Exam:</span></strong><span style=\"font-size:12.0pt\"> Pericardial friction rub.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Labs:</span></strong><span style=\"font-size:12.0pt\"> Elevated CRP, slightly elevated but unchanged troponin.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">ECG:</span></strong><span style=\"font-size:12.0pt\"> New ST elevations (due to pericardial inflammation).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Acute pericarditis:</span></strong><span style=\"font-size:12.0pt\"> Less likely given the recent MI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pulmonary embolism:</span></strong><span style=\"font-size:12.0pt\"> Unlikely with unchanged troponin and ECG findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Recurrent MI:</span></strong><span style=\"font-size:12.0pt\"> Unlikely with unchanged troponin and ECG findings suggestive of pericarditis.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dressler&#39;s syndrome is a post-MI pericarditis that occurs after 1-2 weeks. </span></span></span></p>",
      "correct_choice_id": 214306,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53709,
      "choices": [
        {
          "id": 214309,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bartonella serology </span></span></span></p>"
        },
        {
          "id": 214310,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Epstein-Barr virus heterophile antibody </span></span></span></p>"
        },
        {
          "id": 214311,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HIV polymerase chain reaction </span></span></span></p>"
        },
        {
          "id": 214312,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Q fever serology</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 38-year-old homeless man presents with TIA, fever, chills, tender splenomegaly, new painful nodules on fingers, and nits on clothes. Blood cultures are negative, but echo reveals aortic valve vegetation. What test should be sent to confirm the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q1862658",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022962,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Bartonella serology</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient has culture-negative endocarditis. Culture-negative endocarditis accounts for &lt;10% of cases in all populations. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A common reason for negative blood cultures is prior antibiotics. In the absence of this,&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">the two most common pathogens are Q fever, or Coxiella burnetii (typically associated with close contact with livestock), and Bartonella. In this case, the patient&rsquo;s homelessness and body louse infestation are clues for B. quintana infection. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diagnosis is made by blood culture about 25% of the time. Otherwise, direct PCR of valvular tissue, if available, or acute and convalescent serologies are diagnostic options. Empirical therapy for culture-negative endocarditis usually includes ceftriaxone + gentamicin, with or without doxycycline. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><em><u><span style=\"font-size:12.0pt\">For confirmed Bartonella endocarditis, optimal therapy is gentamicin + doxycycline</span></u></em></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Epstein-Barr virus heterophile antibody:</span></strong><span style=\"font-size:12.0pt\"> EBV does not typically cause endocarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. HIV polymerase chain reaction:</span></strong><span style=\"font-size:12.0pt\"> HIV does not cause endocarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Q fever serology:</span></strong><span style=\"font-size:12.0pt\"> While Q fever can cause culture-negative endocarditis, the patient&#39;s history and presentation are more consistent with Bartonella infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Two most common pathogens responsible for culture negative endocarditis re</span></span></span></p>",
      "correct_choice_id": 214309,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53999,
      "choices": [
        {
          "id": 215465,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Focal segmental glomerulosclerosis (FSGS)</span></span></span></p>"
        },
        {
          "id": 215466,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Hypertensive nephrosclerosis </span></span></span></p>"
        },
        {
          "id": 215467,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Minimal change disease </span></span></span></p>"
        },
        {
          "id": 215468,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Crescentic glomerulonephritis</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old obese woman with controlled hypertension has nephrotic-range proteinuria and mild edema. Renal biopsy reveals segmental scarring in 60% of glomeruli, mainly at the corticomedullary junction. Which diagnosis is most likely?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-163558.jpg\" style=\"height:240px; width:350px\" /></span></span></p>",
      "unique_key": "Q5623780",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022963,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Ans. A) Focal segmental glomerulosclerosis (FSGS)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">FSGS:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;The biopsy finding of segmental scarring in a subset of glomeruli, especially in the corticomedullary junction, is characteristic of FSGS. Additionally, the patient&#39;s obesity is a known risk factor for FSGS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B. Hypertensive nephrosclerosis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;While the patient has hypertension, the biopsy findings do not fit the typical pattern of nephrosclerosis (arteriolosclerosis and global glomerulosclerosis).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C. Minimal change disease:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;This would usually present with less severe proteinuria and no glomerular scarring on biopsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D. Crescentic glomerulonephritis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;This is a rapidly progressive form of glomerulonephritis with crescents (proliferations of cells) on biopsy, not present in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Focal segmental glomerulosclerosis (FSGS) is characterized by segmental scarring in a subset of glomeruli, often associated with obesity.</span></span></span></p>",
      "correct_choice_id": 215465,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19797,
      "choices": [
        {
          "id": 79149,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Human herpesvirus 8 (HHV-8) </span></span></span></p>"
        },
        {
          "id": 79150,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Epstein-Barr virus (EBV) </span></span></span></p>"
        },
        {
          "id": 79151,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Human papillomavirus (HPV) </span></span></span></p>"
        },
        {
          "id": 79152,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Human T-lymphotropic virus 1 (HTLV-1)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old man with HIV presents with multiple violet-colored skin lesions and lymphadenopathy. The lesion is shown below. Which of the following is the most common etiological agent for his skin condition?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/06/screenshot-2024-08-06-162222.jpg\" style=\"height:199px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q7163034",
      "question_audio": null,
      "question_video": null,
      "map_id": 16022964,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Human herpesvirus 8 (HHV-8)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presentation is consistent with Kaposi sarcoma (KS), a malignancy strongly associated with HHV-8 infection, particularly in immunocompromised individuals like those with HIV. While EBV can cause lymphoma, it doesn&#39;t typically present with skin lesions. HPV is linked to various cancers but not KS. HTLV-1 causes adult T-cell leukemia/lymphoma, which has a different presentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Epstein-Barr virus (EBV):&nbsp;</span></strong><span style=\"font-size:12.0pt\">While EBV is associated with several malignancies (lymphoma, nasopharyngeal carcinoma), it doesn&#39;t typically cause the characteristic skin lesions seen in Kaposi sarcoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Human papillomavirus (HPV):&nbsp;</span></strong><span style=\"font-size:12.0pt\">HPV is primarily associated with cervical cancer and other anogenital cancers. It doesn&#39;t cause the type of lesions seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Human T-lymphotropic virus 1 (HTLV-1):&nbsp;</span></strong><span style=\"font-size:12.0pt\">HTLV-1 is associated with adult T-cell leukemia/lymphoma, a type of blood cancer. It doesn&#39;t usually cause the distinctive skin lesions of Kaposi sarcoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HHV-8 is the causative agent of Kaposi sarcoma, a malignancy often seen in HIV-infected individuals.</span></span></span></p>",
      "correct_choice_id": 79149,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19798,
      "choices": [
        {
          "id": 79153,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">gamma rays </span></span></span></p>"
        },
        {
          "id": 79154,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">UVB </span></span></span></p>"
        },
        {
          "id": 79155,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">x-rays </span></span></span></p>"
        },
        {
          "id": 79156,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">alpha - rays</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following types of UV radiation is MOST strongly linked to the development of skin cancer?</span></span></span></p>",
      "unique_key": "Q8953046",
      "question_audio": null,
      "question_video": null,
      "map_id": 16023085,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) UVB</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">UVB radiation is a type of ultraviolet radiation that has a shorter wavelength than UVA but a longer wavelength than UVC. It is the most damaging type of UV radiation that reaches the Earth&#39;s surface. UVB radiation is absorbed by the DNA in skin cells, causing damage that can lead to mutations and the development of skin cancer. &nbsp; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. gamma rays:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Gamma rays are a type of ionizing radiation with very short wavelengths and high energy. While they are carcinogenic, they are not the primary type of radiation associated with skin cancer. &nbsp; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. x-rays:&nbsp;</span></strong><span style=\"font-size:12.0pt\">X-rays are also a type of ionizing radiation with shorter wavelengths than UV radiation. They are used in medical imaging and can also be carcinogenic, but their primary association is not with skin cancer. &nbsp; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. alpha-rays:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Alpha rays are a type of particle radiation consisting of two protons and two neutrons. They have low penetrating power and are not associated with skin cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">UVB radiation is the most significant contributor to skin cancer development.</span></span></span></p>",
      "correct_choice_id": 79154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54001,
      "choices": [
        {
          "id": 215473,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">1-3 weeks</span></span></span></p>"
        },
        {
          "id": 215474,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2-6 weeks</span></span></p>"
        },
        {
          "id": 215475,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3-8 weeks</span></span></p>"
        },
        {
          "id": 215476,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">2-6 days</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">A 5-year-old boy presents with hematuria and edema, three weeks after a confirmed case of impetigo. Which of the following is the most appropriate time frame for the development of post-streptococcal glomerulonephritis (PSGN) following impetigo?</span></span></span></p>",
      "unique_key": "Q8294364",
      "question_audio": null,
      "question_video": null,
      "map_id": 16023086,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Ans. B) 2-6 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">The typical time frame for the development of PSGN after impetigo is 2-6 weeks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option A. 1-3 weeks:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> This time frame is too short for PSGN to develop after a streptococcal infection like impetigo.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C. 3-8 weeks:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> While PSGN can occasionally present slightly later, the most typical window is within the first 2-6 weeks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D. 2-6 days:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> This time frame is far too short. PSGN takes weeks, not days, to manifest.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-streptococcal glomerulonephritis (PSGN) is an immune-mediated complication that can occur after a streptococcal infection. The classic presentation includes hematuria (blood in the urine), edema (swelling) and hypertension. The most common time frame for the development of PSGN following a streptococcal infection is <strong>2-6 weeks</strong>. Recognizing this typical time frame is crucial for timely diagnosis and management of PSGN.</span></span></p>",
      "correct_choice_id": 215474,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54003,
      "choices": [
        {
          "id": 215481,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangial cell proliferation </span></span></p>"
        },
        {
          "id": 215482,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linear IgG deposits along the glomerular basement membrane </span></span></p>"
        },
        {
          "id": 215483,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Subepithelial immune complex deposits </span></span></span></p>"
        },
        {
          "id": 215484,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangial IgA deposits</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old man presents with hemoptysis (coughing up blood), shortness of breath and hematuria. His serum creatinine is elevated. A renal biopsy is taken and immunofluorescence is shown below. Given the likely diagnosis, what would be the immunofluorescence findings?&nbsp; </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-164723_IdSR2Ar.jpg\" style=\"height:225px; width:309px\" /></p>\r\n\r\n<p>&nbsp;</p>",
      "unique_key": "Q8036055",
      "question_audio": null,
      "question_video": null,
      "map_id": 16023087,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Ans. B) Linear IgG deposits along the glomerular basement membrane</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Linear IgG deposits on immunofluorescence are a hallmark of anti-GBM disease, the underlying cause of Goodpasture syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option A. Mesangial cell proliferation:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> Is seen in IgA nephropathy and other conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C. Subepithelial immune complex deposits:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> Are characteristic of membranous nephropathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D. Mesangial IgA deposits:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> Are seen in IgA nephropathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational Objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Linear IgG deposits along the glomerular basement membrane on immunofluorescence are characteristic of Goodpasture syndrome (anti-GBM disease).</span></span></span></p>",
      "correct_choice_id": 215482,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54007,
      "choices": [
        {
          "id": 215497,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">IgA nephropathy </span></span></span></p>"
        },
        {
          "id": 215498,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Thin basement membrane nephropathy (TBMN) </span></span></span></p>"
        },
        {
          "id": 215499,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Alport syndrome </span></span></span></p>"
        },
        {
          "id": 215500,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Minimal change disease (MCD)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">A 10-year-old boy presents with recurrent hematuria and a family history of kidney disease, on further questioning he has difficulty in hearing since childhood. A renal biopsy reveals thin glomerular basement membranes (GBMs) on electron microscopy. Which of the following is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q2885120",
      "question_audio": null,
      "question_video": null,
      "map_id": 16023088,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Ans. C) Alport syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Thin GBM is an early and characteristic finding in young Alport syndrome patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option A</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">. </span><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">IgA nephropathy:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;Presents with mesangial IgA deposits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B. Thin basement membrane nephropathy</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> (</span><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">TBMN)</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">:&nbsp;This is a benign condition with persistent thin GBM,&nbsp;but no progression to multilamellation or other Alport features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D. Minimal change disease (</span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">MCD):</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;Does not cause thinning of the GBM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Alport syndrome is primarily inherited in an X-linked dominant pattern (approximately 85%), but 15% of cases follow an autosomal recessive pattern.</span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Thin glomerular basement membranes (GBMs) on electron microscopy, combined with recurrent hematuria and a family history of kidney disease and hearing loss, are suggestive of Alport syndrome.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 215499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54010,
      "choices": [
        {
          "id": 215509,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Proteinuria &gt; 3.5 g/day </span></span></span></p>"
        },
        {
          "id": 215510,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Hypoalbuminemia </span></span></span></p>"
        },
        {
          "id": 215511,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Hyperlipidemia </span></span></span></p>"
        },
        {
          "id": 215512,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Hyperkalemia</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a typical feature of nephrotic syndrome?</span></span></p>",
      "unique_key": "Q6938068",
      "question_audio": null,
      "question_video": null,
      "map_id": 16023089,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>D) Hyperkalemia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Hyperkalemia is not a characteristic finding in nephrotic syndrome. In fact, hypokalemia can occur due to diuretic use or other factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option A. Proteinuria &gt; 3.5 g/day:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> This is a hallmark of nephrotic syndrome. The excessive loss of protein in the urine is a defining characteristic.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B. Hypoalbuminemia:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> This occurs due to the significant loss of albumin (a protein) in the urine, leading to low albumin levels in the blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C. Hyperlipidemia:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> The liver tries to compensate for the protein loss by increasing the production of lipids (fats), leading to high levels of cholesterol and triglycerides in the blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Nephrotic syndrome is characterized by a constellation of findings, including heavy proteinuria, low albumin levels, and elevated lipids. Hyperkalemia (high potassium) is not typically associated with nephrotic syndrome; in fact, <strong>hypokalemia</strong> (low potassium) is more common due to urinary losses.</span></span></span></p>",
      "correct_choice_id": 215512,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54011,
      "choices": [
        {
          "id": 215513,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Sub-endothelial immune complex deposits </span></span></span></p>"
        },
        {
          "id": 215514,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Mesangial electron-dense deposits </span></span></span></p>"
        },
        {
          "id": 215515,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Thinning of the glomerular basement membrane </span></span></span></p>"
        },
        {
          "id": 215516,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Effacement of podocyte foot processes</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old boy presents with generalized edema, massive proteinuria, and hypoalbuminemia. Given the likely diagnosis, what would be electron microscopic findings would be present in this patient? </span></span></p>",
      "unique_key": "Q6510499",
      "question_audio": null,
      "question_video": null,
      "map_id": 16023090,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>D) Effacement of podocyte foot processes</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">The clinical presentation of generalized edema, massive proteinuria, and hypoalbuminemia is consistent with nephrotic syndrome. In children, the most common cause of nephrotic syndrome is minimal change disease. The hallmark of MCD on electron microscopy is the effacement of podocyte foot processes, which are essential for the glomerular filtration barrier.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option A. Sub-endothelial immune complex deposits:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;This is typically seen in lupus nephritis and other immune-complex mediated glomerulonephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B. Mesangial electron-dense deposits:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;This is characteristic of IgA nephropathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C. Thinning of the glomerular basement membrane:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;This is seen in thin basement membrane nephropathy,&nbsp;a benign condition with minimal proteinuria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation strongly suggests <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">minimal change disease (MCD)</span></strong>, which is the most common cause of nephrotic syndrome in children. The hallmark electron microscopic finding in MCD is the <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">effacement (flattening or fusion) of podocyte foot processes</span></strong>. These foot processes are crucial for the filtration barrier in the glomerulus and their damage leads to the massive proteinuria seen in nephrotic syndrome.</span></span></span></span></p>",
      "correct_choice_id": 215516,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54015,
      "choices": [
        {
          "id": 215529,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">MPGN type I </span></span></span></p>"
        },
        {
          "id": 215530,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">MPGN type II </span></span></span></p>"
        },
        {
          "id": 215531,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">MPGN type III </span></span></span></p>"
        },
        {
          "id": 215532,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Alport syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is associated with &ldquo;tram-track&rdquo; appearance of renal biopsy? </span></span></p>",
      "unique_key": "Q2505062",
      "question_audio": null,
      "question_video": null,
      "map_id": 16023091,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>A) MPGN type I</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">The &quot;tram-track&quot; appearance is due to mesangial interposition between the GBM and endothelial cells, a characteristic finding in MPGN type I.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B. MPGN type II:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> &nbsp;Shows dense deposits within the GBM,&nbsp;not the tram-track appearance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C. MPGN type III:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> &nbsp;Is similar to type I but with less prominent mesangial interposition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D. Alport syndrome:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> Shows splitting and lamellation of the GBM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">The &quot;tram-track&quot; appearance on renal biopsy is a hallmark of MPGN type I due to the characteristic mesangial interposition. This distinctive finding helps differentiate MPGN type I from other glomerular diseases.</span></span></span></p>",
      "correct_choice_id": 215529,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54016,
      "choices": [
        {
          "id": 215533,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">The majority of patients will experience spontaneous remission within 5 years. </span></span></span></p>"
        },
        {
          "id": 215534,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Renal function typically remains stable for at least 20 years after diagnosis. </span></span></span></p>"
        },
        {
          "id": 215535,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Approximately 50% of patients will develop end-stage renal disease (ESRD) within 10 years. </span></span></span></p>"
        },
        {
          "id": 215536,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Early treatment with corticosteroids can prevent progression to ESRD in most cases.</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old patient is newly diagnosed with idiopathic membranoproliferative glomerulonephritis (MPGN) type I. Which of the following statements regarding their prognosis is MOST accurate?</span></span></p>",
      "unique_key": "Q7400597",
      "question_audio": null,
      "question_video": null,
      "map_id": 16023092,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>C) Approximately 50% of patients will develop end-stage renal disease (ESRD) within 10 years</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">MPGN type I is a progressive disease, and studies have shown that about 50% of patients will develop ESRD within 10 years of diagnosis. This underscores the importance of early diagnosis and appropriate management to slow disease progression.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>The majority of patients will experience spontaneous remission within 5 years</strong>:&nbsp; Spontaneous remission is rare in MPGN type I.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>Renal function typically remains stable for at least 20 years after diagnosis:&nbsp; </strong>Renal function typically declines over time,&nbsp;with 90% of patients developing renal insufficiency within 20 years.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>Early treatment with corticosteroids can prevent progression to ESRD in most cases: </strong>&nbsp;While corticosteroids may be beneficial in some cases,&nbsp;they do not guarantee prevention of ESRD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">MPGN type I is a progressive disease with a poor prognosis. Approximately half of the patients progress to ESRD within 10 years, emphasizing the need for early diagnosis and management to potentially slow disease progression. While treatments like corticosteroids may be used, they do not guarantee prevention of ESRD.</span></span></span></p>",
      "correct_choice_id": 215535,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}